Fernández-RodrÃguez, Diana
Cho, Jeongeun
Chisari, Emanuele
Citardi, Martin J.
Parvizi, Javad
Clinical trials referenced in this document:
Documents that mention this clinical trial
Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial
https://doi.org/10.1038/s41598-023-46792-8
Article History
Received: 30 May 2023
Accepted: 5 November 2023
First Online: 20 July 2024
Competing interests
: EC reports personal fees from Biolumen Inc., Cardinal Health Inc, ICMI LLC, MicrogenDx Inc., Probiotical SPA, personal fees and stocks from Parvizi Surgical Innovation LLC, stocks from Povinez LLC, CIRO LLC, and Surgiwipe LLC. JP reports personal fees and stock option from Corentec, personal fees from Data Trace, personal fees from Elsevier, personal fees from Jaypee Publishers, personal fees from SLACK Incorporated, personal fees from Wolters Kluwer, personal fees from Becton Dickensen, personal fees and non-financial support from Zimmer Biomet, personal fees from Ethicon, personal fees from Tenor, personal fees from KCI/3M (Acelity), personal fees from MicroGenDx, personal fees from Jointstem, personal fees from Becton Dickenson, personal fees from Cardinal Health, stock option from Parvizi Surgical Innovation and Subsidiaries, stock option from Hip Innovation Technology, stock option from Alphaeon/Strathsby Crown, stock option from Elute, stock option from Ceribell, stock option from Acumed, stock option from PRN-Veterinary, stock option from Illuminus, stock option from Intellijoint, stock option from Osteal, stock option from Nanooxygenic, stock option from Sonata, stock option from Molecular Surface Technologies, stock option from Peptilogic, non-financial support from NIH, non-financial support from OREF, non-financial support from 3M, non-financial support from Aesculap, non-financial support from AO Spine, non-financial support from Biomet, non-financial support from Cempra, non-financial support from DePuy, non-financial support from Integra, non-financial support from Lima, non-financial support from Myoscience, non-financial support from NDRI, non-financial support from Novartis, non-financial support from Pfizer, non-financial support from Rotation Medical, non-financial support from Simplify Medical, non-financial support from Smith & Nephew, non-financial support from Stelkast, non-financial support from Stryker Orthopedics, non-financial support from Synthes, non-financial support from TissueGene, non-financial support from Tornier, non-financial support from Orthospace, outside the submitted work. All other authors declare no financial or non-financial competing interests.